YAVNE, Israel, June 5, 2013 (GLOBE NEWSWIRE) -- Andromeda Biotech Ltd. announces the results from an Extension Study to its Phase III Clinical trial in type 1 diabetes patients treated with...
TEL AVIV, Israel, Sept. 24, 2012 (GLOBE NEWSWIRE) -- Clal Biotechnology, (TASE:CBI), a leading investment company in the field of life sciences, is pleased to announce that the Committee for...
NEW YORK, Nov. 28 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, November 29, 2005 on the following American Stock Exchange and New York...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 0.00 (0.00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | US$ 0.00 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 0.00 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | US$ 0.00 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | US$ 0.00 (0.00%) | 0 |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約